Scientists criticize president of committee nominated to examine Italy's Stamina Foundation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
07 February 2014
An earlier version of this article stated that in his appearance on Le Iene, "[Mauro] Ferrari said he thought Stamina offered Italy the opportunity to take a world lead in bringing experimental therapies into the clinic." Ferrari's statement however did not explicitly refer to Stamina's approach as being what offered such an opportunity. The article has also been revised to include Ferrari's clarification of his statement regarding the Stamina case being "the first important case for regenerative medicine here in Italy".
Additional information
See Correspondence ‘Stamina therapies: Time to call a halt’ and ‘Stamina therapies: Let the record stand’
Related links
Related links
Related links in Nature Research
Stamina therapies: Time to call a halt 2014-Feb-26
Stamina therapies: Let the record stand 2014-Feb-26
Leaked files slam stem-cell therapy 2014-Jan-07
Stem-cell fiasco must be stopped 2013-Dec-13
Italian court rules science advisers unlawful 2013-Dec-04
Stem-cell ruling riles researchers 2013-Mar-26
Advisers declare Italian stem-cell therapy ‘unscientific’
Minister halts Italian stem-cell therapy trial
Related external links
Rights and permissions
About this article
Cite this article
Abbott, A. Row over controversial stem-cell procedure flares up again. Nature (2014). https://doi.org/10.1038/nature.2014.14613
Published:
DOI: https://doi.org/10.1038/nature.2014.14613
